Pharmafile Logo
Pharmafocus logo
Advanced Search
Allergan

Allergan recalls eye drugs after complaints of blurred vision

August 25, 2015
Manufacturing and Production Allergan, manufacturing, product recalls, production, recalls

Allergan has issued a recall for batches of eye ointments sold in the US, after customers complained of foreign bodies …

News
Takeda oncology

Takeda in Velcade patent blow

August 25, 2015
Manufacturing and Production Actavis, Sandoz, Takeda, Velcade, bortezomib, ixazomib

Takeda has lost a court case contesting the patent for its blockbuster multiple myeloma drug Velcade, in a decision that …

News
sean_bohen

AZ appoints Genentech’s Sean Bohen as chief medical officer

August 25, 2015
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison, Sean Bohen

AstraZeneca has appointed Dr Sean Bohen as executive vice president of global medicines development and chief medical officer.Dr Bohen will …

Appointment

Clinical Trial Transparency – A Personal View

August 24, 2015
Research and Development ABPI, PMCPA, clinical trial transparency, clinical trials, health research authority, transparency

During the time I worked as research, medical and innovation director at the ABPI, between October 2012 and January 2015, …

Feature
research lab

AstraZeneca cancer drug trialled for pancreatic cancer

August 24, 2015
Research and Development

AstraZeneca is working with the Banner MD Anderson Cancer Center in Arizona to test its cancer drug Lynparza as a …

News
Logos

AstraZeneca and Peregrine in immuno-oncology collaboration

August 24, 2015
Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours

AstraZeneca and Peregrine Pharmaceuticals will collaborate on a clinical trial to test two of the companies’ cancer treatments. The Phase …

News
Health secretary Jeremy Hunt

Doctors ‘face jail over pharma payments’

August 24, 2015
Sales and Marketing ABPI, Jeremy Hunt, NHS, PMCPA, bribery, doctor payments, health secretary, transparency

Healthcare professionals who have inappropriate financial links with pharma companies will face prosecution and up to 10 years in jail, …

News

Takeda gets European MAA approval for ixazomib

August 21, 2015
Medical Communications, Research and Development (FDA/EMA/MHRA), FDA/EMA/MHRA, Takeda, ixazomib, multiple myeloma

Takeda has announced that the European Medicines Agency (EMA) has accepted its Marketing Authorisation Application (MAA) for ixazomib, an investigational …

News
novartis

Novartis buys rights to GSK MS drug for up to $1 billion

August 21, 2015
Medical Communications, Research and Development, Sales and Marketing GlaxoSmithKline, Novartis, multiple sclerosis, ofatumumab

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline’s …

News
lilly_corporate_hq

Lilly and Boehringer’s Jardiance diabetes drug reduces cardiovascular risks

August 21, 2015
Medical Communications, Research and Development Boehringer Ingelheim, Eli Lilly, diabetes drugs

Eli Lilly’s diabetes drug Jardiance (empagliflozin) has shown in a study to be the very first blood sugar lowering drug …

News
sun_pharma_hq

Sun Pharma gets FDA approval for acne treatment

August 21, 2015
Medical Communications, Research and Development, Sales and Marketing Sun Pharma. acne treatments, drug approvals

The FDA has approved Sun Pharma’s new acne treatment, Ximino.The Ximino (minocycline hydrochloride) extended-release capsules, which will be available in …

News

Horizon Pharma receives third rejection from Depomed

August 21, 2015
Sales and Marketing Depomed, Horizon Pharma, pharma mergers and acquisitions

Depomed has announced that its board has unanimously rejected Horizon Pharma’s third proposal to buy the California-based company. Following its …

News
259612

Monique Levy joins Google’s healthcare advisory board

August 20, 2015
Medical Communications google

Monique Levy, vice president of digital innovation at healthcare data and analytics firm Decision Resources Group, is joining Google’s healthcare …

Appointment
Pharma pill manufacturing

FDA hits Mylan’s Indian plants with warning letter

August 20, 2015
Manufacturing and Production Contamination, FDA, Mylan, Pfizer, manufacturing, production

The FDA has served Mylan with a warning letter citing contamination at three of its manufacturing facilities in India. Inspections …

News
Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …

News
Sprout sign

Valeant confirms $1bn deal for ‘female viagra’ creator Sprout

August 20, 2015
Manufacturing and Production, Sales and Marketing Addyi, Sprout, Sprout Pharma, Sprout Pharmaceuticals, Valeant, flibanserin

Canada’s Valeant Pharmaceuticals has confirmed it will pay $1 billion to acquire Sprout Pharmaceuticals, the company behind the female libido …

News

Lundbeck sheds 1,000 jobs in £284 million restructure

August 20, 2015
Manufacturing and Production, Sales and Marketing Lundbeck, generics, job losses, patents, redundancies, restructure, restructuring

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …

News
amgen_flag

Amgen agrees to $71m settlement over false advertising

August 19, 2015
Sales and Marketing Amgen, Aranesp, Enbrel

Amgen has reached a $71 million settlement with 48 US states and the District of Columbia, to resolve allegations that …

News
Sprout sign

FDA approves ‘female viagra’

August 19, 2015
Research and Development, Sales and Marketing Addyi, FDA, HSDD, Sprout, Sprout Pharmaceuticals, flibanserin, hypoactive sexual desire disorder

The FDA has approved Sprout Pharmaceuticals’ Addyi, a controversial libido-enhancing drug for women that has been dubbed the ‘female viagra’. …

News
BioScience Nottingham

Nottingham receives go ahead for new £30m life science facility

August 19, 2015
Manufacturing and Production, Research and Development BioCity Nottingham, R&D

Hundreds of pharma jobs are expected to be created in Nottingham after the construction of a new £30 million life …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026